BioSpace News Archive

Biotech Bay

Kandu Health Announces Preliminary Clinical Outcomes for Stroke Survivors

Kandu Health, Inc. today announced preliminary outcomes from the first 40 stroke survivors served by its program.

July 31, 2023
·
5 min read
Study Confirms Effectiveness of Trilaciclib for Treatment of Patients with Extensive-Stage Small Cell Lung Cancer Co-authored by Florida Cancer Specialists & Research Institute Physicians and Senior Leaders

Florida Cancer Specialists & Research Institute, LLC (FCS) physicians and senior leaders are co-authors of a study that confirms the effectiveness of trilaciclib for the treatment of adult patients with Extensive-Stage Small Cell Lung Cancer.

July 31, 2023
·
3 min read
Pharm Country

Globus Medical Announces Launch of the MARVEL™ Growing Rod System, the company’s first product designed specifically for early onset scoliosis

Globus Medical, Inc. announced the commercial launch of the MARVEL™ Growing Rod System, which is designed for pediatric patients with early onset scoliosis to obtain and maintain correction while allowing for growth through minimally invasive distraction.

July 31, 2023
·
4 min read
Deals

TC BioPharm Maintains Nasdaq Listing

TC BioPharm announced that the Company has regained compliance with the Nasdaq Stock Market Listing Rule 5550(b) which will maintain the listing of the Company’s American depositary shares on the Nasdaq Global Select Market.

July 31, 2023
·
2 min read
Biotech Beach

Gracell Biotechnologies to Participate in BTIG Virtual Biotechnology Conference

Gracell Biotechnologies Inc. today announced that the management team will participate in the BTIG Virtual Biotechnology Conference on August 7 - 8.

July 31, 2023
·
1 min read
China’s National Medical Products Administration Accepts Astellas’ Biologics License Application for Zolbetuximab

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has accepted the Biologics License Application (BLA) for zolbetuximab.

July 31, 2023
·
10 min read
Business

DBV Technologies Receives Feedback from FDA on Design Elements for Viaskin Peanut Safety Studies and Reports Second Quarter and Half-Year 2023 Financial Results

DBV Technologies announced the receipt of Written Responses from the FDA on key study design elements for the COMFORT Toddlers and COMFORT Children supplemental safety studies in 1 – 3-year-olds and 4 – 7-year-olds, respectively, with a peanut allergy.

July 31, 2023
·
12 min read
Business

enVVeno Medical Reports Second Quarter 2023 Financial Results and Provides Corporate Update

enVVeno Medical Corporation (NASDAQ:NVNO) (“enVVeno” or the “Company”), a company setting new standards of care for the treatment of venous disease, today provided a corporate update and reported financial results for the second quarter ended June 30, 2023.

July 31, 2023
·
6 min read
Everest Medicines Announces Completion of Patient Enrollment in Nefecon® China Open Label Extension Study

Everest Medicines, a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced the completion of patient enrollment for the China open-label extension of the Phase 3 NefIgArd study.

July 31, 2023
·
4 min read
Deals

T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirements

T2 Biosystems, Inc. announced today that the Nasdaq Hearings Panel (the “Panel”) has granted the Company’s request for an extension through November 20, 2023, to evidence compliance with Nasdaq’s minimum bid price and market value of listed securities (“MVLS”) requirements.

July 31, 2023
·
4 min read